Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis

Not Applicable

Completed

• Conditions: Knee Osteoarthritis; Energy Transfer Capacitative and Resistive Therapy

• Registration Number: NCT06418360
• Lead Sponsor: Ankara City Hospital Bilkent

Brief Summary

Objective: The aim of the present study was to investigate the treatment efficacy of TECAR therapy, a modern application that has been increasingly used in recent years, compared to conventional physical therapy applications in the treatment of knee osteoarthritis, according to the evaluation of the clinical findings of patients.

Methods: A total of 54 patients, aged between 40 and 75 years, were randomly divided into two groups. Both groups received CPT. Group 2 received TECAR therapy in addition to CPT, applied three times a week for two weeks, for a total of 6 sessions. All patient's knee joint range of motion (ROM) was measured goniometrically, isometric quadriceps muscle strength was measured, and pain levels were assessed using the Visual Analog Scale (VAS), and disability levels were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) before treatment, at the end of treatment, at 1 month, and at 3 months.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-13
• Primary Completion: 2023-08-23
• Study Completion: 2023-11-23
• Status Verified: 2024-05
• Study First Submitted: 2024-05-06
• Study First Submitted QC: 2024-05-13
• Last Update Submitted: 2024-05-13
• Study First Posted: 2024-05-17
• Last Update Posted: 2024-05-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• 3 months of conservative treatment for unresponsive knee pain
• Kellgren-Lawrence grade 2-3 on radiographic evaluation
• Agreed to participate in the study.

Exclusion Criteria

• History of physical therapy (electrotherapy/exercise) in the past 3 months
• Intra-articular injection therapy in the past 3 months,
• History of surgery or trauma to the affected knee
• Inflammatory or neurological disease affecting the lower extremities
• Active vasculitis or severe peripheral vascular disease
• Pregnancy or lactation
• Diagnosed restless legs syndrome
• Neoplasia
• Local sensory impairment,
• Local or systemic acute infections
• Severe osteoporosis
• Pacemaker
• Psychiatric disorder and cognitive impairment.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Visual Analog Scale (VAS)	Before and the after treatment 0th day , 1th month, 3rd month	0 min , 10 is maximum pain score
Range of Motion (ROM)	Before and the after treatment 0th day, 1th month, 3rd month	Flexion and extension of the knee joint were measured using a universal goniometer relative to reference points.
Western Ontario and McMaster Universities Arthritis Index (WOMAC)	Before and the after treatment 0th day, 1th month, 3rd month	This 24-item index comprises three subscales: pain, stiffness, and physical function, each measured on a five-point Likert scale ranging from "none" to "extreme."

Secondary Outcome Measures

Name	Time	Method
The Diers Myoline Isometric Muscle Strength Measurement System	Before and the end of treatment 0th day, 1th month, 3rd month	quadriceps muscle Isometric Strength Measure: Increased isometric muscle strength is an indicator of recovery.

Trial Locations

Locations (1)

Özge TEZEN; 🇹🇷 Ankara, Turkey